FRM
IMGN

Fox Run Management’s Immunogen Inc IMGN Stock Holding History

Fox Run Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,270
Closed -$60.9K – 985
2022
Q4 		$60.9K Sell
12,270
-9,581
-44% -$51.9K 0.02% 578
2022
Q3 		$104K Buy
+21,851
New +$115K 0.04% 546
2022
Q1 		– Sell
-10,370
Closed -$77K – 751
2021
Q4 		$77K Buy
+10,370
New +$64.4K 0.05% 430
2019
Q1 		– Sell
-15,150
Closed -$73K – 741
2018
Q4 		$73K Buy
+15,150
New +$91.9K 0.04% 473
2016
Q3 		– Sell
-14,300
Closed -$44K – 734
2016
Q2 		$44K Buy
+14,300
New +$89.7K 0.02% 518

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fox Run Management's IMGN Position: Q1 2023 in Review

Fox Run Management sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 12,270 shares — an estimated $60.9K sold.

Fox Run Management first reported a position in IMGN in Q2 2016 and held it in 5 quarters. The position peaked at $104K in Q3 2022. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Fox Run Management reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Fox Run Management sold 12,270 Immunogen Inc shares in Q1 2023, an estimated $60.9K.
  • Fox Run Management first reported a position in Immunogen Inc in Q2 2016 and held it in 5 quarters.
  • Fox Run Management's Immunogen Inc position peaked at $104K in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Fox Run Management's 13F filing for Q1 2023, filed 12 May 2023.